Related Experiment Video
Updated: Feb 23, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care
Khai Hoan Tram1, Florence Mwangwa, Mucunguzi Atukunda
1*Stanford University School of Medicine, Stanford, CA †Infectious Diseases Research Collaboration, Kampala, Uganda ‡Kenya Medical Research Institute, Nairobi, Kenya §Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, CA ‖Makerere University Joint AIDS Program, Kampala, Uganda ¶Makerere University College of Health Sciences, School of Medicine, Kampala, Uganda #University of California, Berkeley School of Public Health, Berkeley, CA.
No abstract available in PubMed .
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Retrovirus Life Cycles
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

